Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 0.00% | -0.94% | 19.03% | -24.67% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 1.85% | 1.56% | 0.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 0.00% | 28.38% | -33.62% | 93.40% |
| Change in Net Operating Assets | 0.00% | 0.00% | -170.47% | -148.99% | 43.84% |
| Cash from Operations | 0.00% | 0.00% | -34.21% | -12.65% | -19.15% |
| Capital Expenditure | 0.00% | 0.00% | 0.00% | -100.00% | 50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00% | 0.00% | 0.00% | -100.00% | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00% | 0.00% | 164.96% | 41.81% | 86.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 0.00% | 164.96% | 41.81% | 86.84% |
| Foreign Exchange rate Adjustments | 0.00% | 0.00% | -197.62% | -148.81% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 0.00% | 170.54% | 1,988.89% | 96.27% |